A vaccine developed by Intervet to help prevent the canine influenza virus H3N8, which has been spreading across the country, has received conditional approval from the USDA.
A vaccine developed by Intervet to help prevent the canine influenza virus H3N8, which has been spreading across the country, has received conditional approval from the USDA. Click here to read more.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.